Cite
APA Citation
Wasserman, R. L., Melamed, I., Kobrynski, L., Puck, J., Gupta, S., Doralt, J., Sharkhawy, M., Engl, W., Leibl, H., Gelmont, D., & Yel, L. (n.d.). recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability. Immunotherapy, 8, 1175–1186. http://access.bl.uk/ark:/81055/vdc_100150250360.0x00000f